Intravenous Infusions

In an open-label extension of the CLARITY-AD study, treatment with IV lecanemab was associated with significant improvement in Alzheimer’s disease-related pathology, continuing a positive treatment effect from the randomization phase.

Despite the benefits and accessibility of administering cancer medications and fluids subcutaneously vs. intravenously, U.S. facilities appear to underuse this delivery method, according to a research letter published in JAMA Oncology.

Subcutaneous insulin therapy was associated with shorter hospital stay and lower cost vs. intravenous insulin infusion for the treatment of mild diabetic ketoacidosis for children with type 1 diabetes, according to study data.